DarioHealth

What DarioHealth does

DarioHealth is a digital therapeutics company founded in 2011 and publicly traded on NASDAQ under the ticker DRIO, headquartered in New York with 101–250 employees. The company operates a multi-condition digital health platform addressing cardiometabolic (diabetes, hypertension, weight management), musculoskeletal (posture, pain, injury), and behavioral health (anxiety, depression, stress) conditions through a single integrated app and ecosystem of FDA-cleared connected devices (glucometer, blood pressure monitor, weighing scale). The platform's core technical layer is DarioIQ, a proprietary AI combining Advisor, Sentinel, and Strategist components trained on over 13 billion real-world data points, with a multi-phase GenAI roadmap. An Oral GLP-1 digital health solution launched in March 2026 extends the platform into medication adherence support, and the company has integrated capabilities from acquired entities Twill (behavioral health, acquired Feb 2024 for $10M) and Physimax (AI-powered MSK screening, acquired Jan 2022).

DarioHealth generates revenue through three primary streams: (1) B2B subscription contracts with self-insured employers and health plans, with milestone-based pricing tied to clinical outcomes and engagement; (2) direct-to-consumer sales of devices, test strips, and individual memberships through its mobile app on iOS and Android; and (3) pharmaceutical industry partnerships and licensing arrangements, including a $30M agreement with Sanofi for digital companion solutions. Distribution occurs through direct enterprise sales, consultant partnerships, a channel partner ecosystem anchored by Solera Health and Amwell (providing access to 116M+ covered lives with potential expansion to 175M+), and DTC app store channels.

The company reports strong customer-outcome metrics including 80% member retention after year one, 3.4–6X partner ROI, a 4.9/5 App Store rating, and clinically validated cost savings of $5,077 per user per year. In Q1 2026 revenue was $5.6M (second consecutive quarter of sequential growth from $5.2M in Q4 2025), operating expenses declined 21% YoY to $10.5M, and operating loss narrowed 22% YoY to $7.3M. The company holds approximately $20M in cash and in April 2026 the Board initiated a comprehensive strategic review with Perella Weinberg Partners as financial advisor following unsolicited inbound expressions of interest.

Name

DarioHealth

Legal name

DarioHealth Corp.

Website

https://dariohealth.com

Company type

Public

Founded year

2011

Headcount range

101–250 employees

Short description

DarioHealth is a digital therapeutics company offering a multi-condition digital health platform for chronic disease management — covering cardiometabolic, musculoskeletal, and behavioral health — serving self-insured employers, health plans, pharmaceutical companies, and individual consumers via connected devices and the DarioIQ AI platform.

Ownership category

akta.pro rank

Product category

Digital Therapeutics

NAICS

Diet and Weight Reducing Centers (812191)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• Digital therapeutics platform
• Chronic disease management
• Remote patient monitoring
• Digital health solutions
• Behavioral health software

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. B2B Enterprise Sales (Employers & Health Plans): Subscription-based contracts with employers and health plans providing access to Dario's digital health platform for their members/employees. Uses milestone-based payment models linking costs to clinical progress and engagement outcomes.
2. Direct-to-Consumer App & Device Sales: Direct consumer sales through mobile app (iOS/Android) and online store, including glucometer devices, test strips, and membership subscriptions for individual chronic condition management.
3. Pharma Services & Partnerships: Partnerships with pharmaceutical companies (Sanofi collaboration mentioned) for digital therapeutics integration with drug therapies, creating bundled offerings to improve patient adherence and outcomes.
4. Healthcare Cost Savings Studies: Value-based arrangements demonstrating cost savings ($5,077 medical cost savings per user per year) that support pricing and reimbursement negotiations with health plans and employers.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

DarioHealth operates a multi-condition digital health platform addressing cardiometabolic (diabetes, hypertension, weight management), musculoskeletal, and behavioral health conditions through its mobile app combined with FDA-cleared connected devices (glucometer, blood pressure monitor, scale). The proprietary DarioIQ AI layer provides personalized guidance, biometric interpretation, and engagement optimization, supported by over 13 billion real-world data points and clinical evidence published in peer-reviewed journals.

Product overview

DarioHealth is a digital health company offering a multi-condition platform for chronic disease management. The core platform includes integrated solutions for Cardiometabolic (diabetes, hypertension, weight), Musculoskeletal (posture, pain, injury), and Behavioral Health (anxiety, depression, stress) conditions. The proprietary DarioIQ AI layer provides personalized guidance, real-time biometric interpretation, and engagement optimization. The company operates on a platform-plus-modules architecture with connected FDA-cleared devices, acquired capabilities from Twill (behavioral health) and Physimax (MSK screening), and offers specialized GLP-1 and Pharma Services modules. Target customers include employers, health plans, healthcare providers, and direct consumers.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiometabolic Solution Integrated solution for metabolic conditions including diabetes management, hypertension control, and weight management with evidence-based personalized approaches. Designed for employers, health plans, and individuals managing metabolic chronic conditions.
• Musculoskeletal Solution Digital solution for improving strength, mobility, and injury prevention covering posture correction, pain management, and injury recovery for musculoskeletal conditions. Delivered via mobile app and incorporates Physimax AI-powered screening technology.
• Behavioral Health Solution Digital behavioral health program providing quick connections to appropriate care for anxiety, depression, and stress management. Includes digital therapeutic content, live coaching, and crisis navigation capabilities from the Twill acquisition.
• GLP-1 Solution Digital health solution providing behavioral support to improve medication adherence and patient outcomes for oral GLP-1 treatments. Includes medication tracking, grocery scanning, and human coaching to optimize GLP-1 investments.
• Pharma Services Pharmaceutical industry partnership services enabling digital therapeutics integration with pharma drug offerings for improved patient adherence and outcomes. Includes digital companion apps, adherence support, and clinical trial integration.
• DarioIQ Proprietary AI layer integrated into the Dario Health app combining three components (Advisor, Sentinel, Strategist) to deliver personalized guidance, real-time biometric interpretation, and patient engagement. Built on over 13 billion real-world data points with demonstrated improvements of up to 40% in member retention and 57% in active sessions versus control.
• Dario Connected Devices FDA-cleared connected devices including a glucometer, blood pressure monitor, and weighing scale for real-time biometric tracking, sold directly through the Dario Store and paired with the Dario Health app.

Quantifiable outcome

• 80% member retention rate after year one
• +15 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core, minor and major.

• Solera HealthcoreChannel Partner/ Reseller/ Distributor · 26 May 2026Solera Health expanded its digital health platform to include Dario's expanded hypertension program, more than doubling Dario's addressable market within the Solera network to more than 500,000 eligible lives. The expansion extends program reach into pre-hypertensive members through Stage 2 hypertension, tying revenue directly to engagement and clinical outcomes.
• John R. PalumbominorOthers · 13 April 2026John R. Palumbo appointed to Board of Directors, bringing over 40 years of healthcare operating experience from Cencora and Veradigm. Expected to support DarioHealth's scaling efforts and transition from distribution model demonstration to efficient scaling.
• Twill (Acquired)majorStrategic or Co-development Partner · 29 February 2024DarioHealth completed a $10 million acquisition of Twill, a provider of digital chronic care solutions, to expand its healthcare platform. The deal included cash, shares, and additional funding, with anticipated increases in revenue and margins.
• Physimax Technologies Ltd. (Acquired)minorStrategic or Co-development Partner · 20 January 2022DarioHealth acquired Physimax Technologies Ltd., a provider of AI-powered musculoskeletal screening and injury risk assessment technology. The deal included stock, cash, and assumed liabilities to enhance Dario's digital therapeutics offerings.
• AmwellcoreChannel Partner/ Reseller/ DistributorAmwell serves as a blue-chip channel partner providing access to its telehealth ecosystem and covered lives, expanding DarioHealth's reach through the channel partner ecosystem.
• SanofimajorStrategic or Co-development Partner$30 million agreement between Sanofi and DarioHealth for digital health platform collaboration, creating bundled drug-and-app offerings to improve patient adherence. Sanofi conducted research demonstrating $5,077 medical cost savings per Dario user.

Scale indicators18 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Omada Health: Multi-condition digital health platform addressing diabetes, hypertension, and musculoskeletal conditions for employers and health plans. Most direct competitor to DarioHealth given similar integrated care model, employer-focused GTM, and cardiometabolic emphasis.
• Virta Health: Digital health company specializing in diabetes reversal and metabolic health through nutrition and remote coaching. Direct competitor in the cardiometabolic space with similar employer/health plan go-to-market motion.
• Noom: Digital health platform addressing weight management, diabetes prevention, and broader cardiometabolic health through behavior change programs. Direct competitor in weight and cardiometabolic with similar employer and consumer channels.
• Hinge Health: Digital musculoskeletal health platform providing exercise therapy and AI-powered motion tracking for MSK conditions. Direct competitor in Dario's MSK solution line with similar employer-focused B2B distribution.
• Sword Health: Digital MSK care platform combining AI motion assessment with virtual physical therapy. Direct competitor in the MSK condition vertical with similar employer and health plan B2B distribution model.
• Welldoc: Digital health company focused on cardiometabolic conditions with FDA-cleared AI-powered platform for diabetes, hypertension, and heart failure. Direct competitor in connected care with similar health plan and pharma partnership models.

Broad incumbents

• Livongo (Teladoc Health): Pioneer in digital chronic condition management, now part of Teladoc Health. Competes across diabetes, hypertension, weight management, and behavioral health within a broader telehealth portfolio serving employers and health plans.
• Verily (Alphabet): Alphabet-owned health technology company with broader precision health portfolio including chronic condition management and research-grade health platforms. Large incumbent with deeper capital and broader capabilities than DarioHealth.

Emerging players

• Headspace Health: Digital mental health platform combining therapy, coaching, and self-guided content. Competes in Dario's behavioral health solution line, primarily focused on mental health versus Dario's multi-condition approach.
• Calm Health: Mental wellness platform with expanding enterprise health offering including therapy, coaching, and self-guided content. Emerging player in the employer behavioral health space overlapping with Dario's anxiety/depression solution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/DarioHealth
• Facebookfacebook.com/DarioHealth
• LinkedInlinkedin.com/company/dariohealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Subsidiaries2 records

Funding overview

Funding rounds22 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DarioHealth